MedPath

Swiss Group for Clinical Cancer Research

🇨🇭Switzerland
Ownership
Private
Established
1965-01-01
Employees
-
Market Cap
-
Website
http://www.sakk.ch/

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Phase 2
Completed
Conditions
Esophageal Cancer
Interventions
First Posted Date
2003-11-06
Last Posted Date
2012-06-05
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
66
Registration Number
NCT00072033
Locations
🇨🇭

Kantonspital Aarau, Aarau, Switzerland

🇨🇭

Universitaetsspital-Basel, Basel, Switzerland

🇨🇭

Inselspital Bern, Bern, Switzerland

and more 6 locations

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Phase 3
Completed
Conditions
Lymphoma
First Posted Date
2003-09-24
Last Posted Date
2019-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
240
Registration Number
NCT00003280
Locations
🇨🇭

Kantonspital Aarau, Aarau, Switzerland

🇨🇭

Office of Walter Weber-Stadelman, Basel, Switzerland

🇨🇭

University Hospital, Basel, Switzerland

and more 7 locations

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: Exemestane+bicalutamide
First Posted Date
2003-07-01
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
5
Registration Number
NCT00031889
Locations
🇨🇭

Kantonspital Aarau, Aarau, Switzerland

🇨🇭

University Hospital, Basel, Switzerland

🇨🇭

Inselspital, Bern, Bern, Switzerland

and more 9 locations

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
Interventions
First Posted Date
2003-06-25
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
75
Registration Number
NCT00030797
Locations
🇨🇭

Inselspital, Bern, Bern, Switzerland

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2003-04-30
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
25
Registration Number
NCT00003757
Locations
🇨🇭

Klinik Hirslanden, Zurich, Switzerland

Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-01-27
Last Posted Date
2019-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
46
Registration Number
NCT00030810
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
Drug: Herceptin™ (Her)
Drug: Herceptin™ (Her) + chemo
First Posted Date
2003-01-27
Last Posted Date
2023-04-18
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
175
Registration Number
NCT00004935
Locations
🇮🇹

European Institute of Oncology, Milan, Italy

🇮🇹

Ospedale di Circolo e Fondazione Macchi, Varese, Italy

🇨🇭

Kantonsspital Aarau, Aarau, Switzerland

and more 14 locations

Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer

Phase 2
Completed
Conditions
Gastric Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Registration Number
NCT00004873
Locations
🇨🇭

Hopital Cantonal Universitaire de Geneva, Geneva, Switzerland

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
34
Registration Number
NCT00031876
Locations
🇨🇭

Inselspital, Bern, Bern, Switzerland

🇨🇭

UniversitaetsSpital, Zurich, Switzerland

Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer

Phase 3
Completed
Conditions
Gastric Cancer
Interventions
Drug: Immediate surgery
Drug: Taxotere-Cisplatin-5FU
First Posted Date
2003-01-27
Last Posted Date
2012-05-15
Lead Sponsor
Swiss Group for Clinical Cancer Research
Target Recruit Count
240
Registration Number
NCT00005060
Locations
🇮🇹

European Institute of Oncology, Milan, Italy

🇨🇭

Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland

🇨🇭

Zentrum fuer Tumordiagnostikund Praevention, St. Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath